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Summary 
Antigens hared by the immune and central nervous ystems (CNS) have been described repeatedly. 
The present study reports the expression of the CD6 lymphocyte differentiation a tigen in normal human 
brain evidenced by immunohistochemistry andNorthern blot analysis. A panel of various anti-CD6 
monoclonal antibodies (mabs) tested on serial cryostat sections identified CD6-positive cells randomly 
scattered in parenchyma of all examined brain areas. Northern blot analysis with a highly sensitive cRNA 
probe revealed a 3.1 kb CD6-specific mRNA in various brain regions, especially in basalganglia and cortex 
cerebellum. Staining with mabs raised against different hematopoietic cell types, as well as hybridization 
with probes specific for the /3- and y-T cell receptor (TCR) chains support the notion that CD6 is 
expressed by original brain cells. The nature of the CD6-positive cell type and possible functions of shared 
antigens in immune and nervous ystems are discussed. 
Introduction 
Traditionally the central nervous ystem (CNS) 
has been considered an 'immunologically privi- 
leged site' (Barker and Billing, ham, 1988) anatomi- 
cally and functionally separated from the immune 
system which itself was postulated to represent a 
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non-innervated tissue. For a few years, however, 
there is increasing evidence for the existence of an 
immune-neuroendocrine connection. Brain lesion 
studies in rodents howed that immunocompetent 
cells can be altered numerically and functionally 
by electrophysiological modifications (Hall et al., 
1978; Katayama et al., 1981). On the other hand, 
an antigenic hallenge can modify electrical and 
biochemical ctivities in brain neurons (Besedow- 
sky et al., 1983a). Furthermore, the presence of 
noradrenergic and possible neuropeptidergic nerve 
fibers in human lymphoid tissues provides a mor- 
phological link between the two adaptive systems 
(Felten et al., 1985). 
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In addition, leukocytes and brain cells have 
been shown to produce identical mediator sub- 
stances. Similar to macrophages, astrocytes are 
able to synthesize T cell stimulating factors such 
as interleukin-1 (IL-1), interleukin-6 (IL-6) and 
tumor necrosis factor-a (TNF-a) (Fontana et al., 
1984). Conversely, different human immuno- 
competent cells were found to release neuroendo- 
crine messengers, such as vasoactive intestinal 
peptide (VIP), adrenocorticotropic hormone 
(ACTH), endorphin-like substances, histamine or 
serotonin (Cutz et al., 1978; Smith and Blalock, 
1981; Besedowsky et al., 1983b). Numerous 
hormones and neurotransmitters have been dem- 
onstrated to stimulate or to depress immune re- 
sponse depending on the kind and dose of the 
modulator substance and the timing of its admin- 
istration (e.g. O'Dorisio et al., 1985; Payan and 
Goetzl, 1985). The involvement of these mes- 
sengers in immunoregulation requires their recog- 
nition by specific receptors on immune ceils as 
reported for a great number of hormones and 
transmitters (Crabtree t al., 1980; Besedowsky et 
al., 1983b; Pert et al., 1985). 
Besides these 'classical' receptors hematopoietic 
and brain cells share common antigenic determi- 
nants. Since the first demonstration f the Thy-1 
antigen expressed in the immune and nervous 
systems of the mouse (Reif and Allen, 1964) anti- 
genic sharing in man has been described re- 
peatedly (Garson et al., 1982; Hauser et al., 1983; 
Schuller-Petrovic et al., 1983; Budka and Majdic, 
1985). At present he significance of the cross-re- 
activity between nervous elements and lympho- 
cytes has not been clarified, but there is increasing 
evidence that shared antigens may be involved in 
the pathogenesis of immune-mediated neurologic 
diseases. For instance, the CD4-antigen found on 
hematopoietic and neural cells has been shown to 
bind the acquired immunodeficiency s ndrome 
(AIDS) virus, causing both immunological and 
brain defects (Maddon et al., 1986; Funke et al., 
1987). Furthermore, common antigens may be in- 
volved in system overlapping interactions. These 
considerations prompted us to search for the ex- 
pression of various lymphocyte differentiation a - 
tigens in normal human brain and found positive 
staining with anti-CD6 reagents. In the present 
study we demonstrate he expression of the CD6 
antigen in several brain regions investigated by 
double-staining technique (alkaline phosphatase 
anti-alkaline phosphatase (APAAP)-Nissl stain- 
ing, double immunoenzymatic labeling) using dif- 
ferent anti-CD6 monoclonal ntibodies (mabs) and 
Northern blot analysis with a CD6-specific RNA 
probe. CD6, previously designated T12, is a cell 
surface glycoprotein of approximately 100 kDa 
and contains intra-chain disulfide bonds postulat- 
ing a domain structure (Swack et al., 1988). It has 
been described as a late differentiation a tigen on 
about 80% of mature T lymphocytes, on a small 
subpopulation f normal B cells and on the major- 
ity of B lymphocytic leukemia cells (Rieber et al., 
1984). So far, neither the structure nor a definite 
physiological function of the CD6 antigen have 
been described. 
Materials and methods 
Cell cultures and tissues 
Cell cultures. All human cell lines were re- 
ceived from the American Type Culture Collec- 
tion (ATCC), Rockville, MD, U.S.A.. The glioma 
cell lines T98 G, U87 MG, U138 MG and 85 
HG-59 were cultured in Eagle's minimum essen- 
tial medium containing non-essential mino acids, 
sodium pyruvate and 10% heat-inactivated fetal 
.calf serum (FCS) in the presence of 5% CO 2 at 
37°C, while A172 and H4 required Dulbecco's 
modified Eagle's medium with 4.5 g/1 glucose and 
10% FCS. Single-cell suspensions of each mono- 
layer culture were obtained by trypsinization 
(0.25%) for 1 rain. 
The human B lymphoma cell line Raji, which 
does not express the CD6 antigen, was grown in 
RPMI 1640 medium supplemented with 5% FCS 
(all media and supplements from Gibco, Karls- 
ruhe, F.R.G.). CD6-positive peripheral blood 
lymphocytes (PBLs) were isolated from heparin- 
ized blood of healthy donors by Ficoll-Hypaque 
(Pharmacia, Uppsala, Sweden) density gradient 
centrifugation according to the protocol of Boyum 
(1976). Cytospin preparations (5 x 10 4 cells per 
slide) were stored at -80 °C until use for stain- 
ing. 
Tissues. The specimens of different human 
brain areas obtained 5-6 h post-mortem were 
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snap frozen in liquid nitrogen and stored at 
- 80 o C (kindly provided through Dr. Mi~ller, De- 
partment of Psychiatry, University of Munich, 
Munich, F.R.G.). Brain tissue showed neither by 
macroscopy nor by light microscopy any neuro- 
pathologic abnormalities. Control material includ- 
ing CD6-positive lymphoid organs (tonsil, thymus) 
and CD6-negative tissues (kidney, liver) was ob- 
tained 20-30 rain after surgical excision and was 
handled in the same way. For immunohistoche- 
mistry serial cryostat sections (15 ~m) were pre- 
pared on 100 ~g/ml poly-L-lysine (Sigma, Deisen- 
hofen, F.R.G.)-coated slides and stored at - 80 ° C. 
Monoclonal antibodies 
All primary mabs were used in appropriate 
concentrations (ranging from 1:50 to 1:1000) 
diluted in Tris-buffered saline (TBS) pH 7.6 con- 
taining 1% human serum. 
CD6 antigen was identified with a panel of ten 
different anti-CD6 mabs recognizing closely re- 
lated epitopes (Knapp et al., 1990). Further stain- 
ing was performed with a monocyte marker (M-M 
42), a common leukocyte marker (anti-LC), with 
mabs directed against different TCR chains (BMA 
031, Identity-T TCR delta 1) and in addition with 
an astrocyte-specific antibody (anti-glial fibrillary 
acidic protein (GFAP)), an anti-human macro- 
phage marker (EBM 11) and an anti-galac- 
tocerebroside antibody (anti-GC). 
Staining specificity was controlled by replacing 
the first antibody (a) with TBS buffer and (b) with 
an anti-CD8 mab (M-T811) of the same im- 
munoglobulin subclass. Sections without primary 
mab or with CD8 as primary mab were always 
negative. A major histocompatibility complex 
(MHC) class I mab (W6/32) was employed as 
positive control for the staining procedure. On 
brain sections only blood vessel endothelium, con- 
nective tissue structures and occasional unidenti- 
fied cells were W6/32 positive, while neurons did 
not stain for MHC class I. The mabs used for 
immunohistochemical studies are summarized in 
Table 1. 
Immunohistochemistry 
APAAP-Nissl staining. Before immunostain- 
ing, cytospins and sections were thawed at room 
temperature, then fixed in acetone ( -20  ° C) and 
subsequently in chloroform for 10 min. After pre- 
incubation with human serum (diluted 1:10 in 
TBS) for 30 min, primary mabs were applied in 
predetermined ilutions. The APAAP-staining 
procedure yielding a red reaction product was 
carried out as described by Mason (1985). After 
washing in TBS a second fixation step with 10% 
formaldehyde for 10 min was performed before 
staining the slides with 0.5% cresyl violet solution 
(pH 3.9, 37 ° C, 30 rain). 
Double immunoenzymatic labeling. In the 
two-enzyme approach the acetone-fixed tissue sec- 
tions were labeled first with the non-conjugated 
primary mab (anti-LC, anti-GFAP, EBM 11) in 
an appropriate dilution for 60 min. After incuba- 
tion with the second antibody (peroxidase-con- 
jugated rabbit anti-mouse IgG and IgM) un- 
specific binding sites were blocked with 2% mouse 
serum for 30 rain. Subsequently the biotin-labeled 
anti-CD6 mab (T 152) was applied for 1 h, fol- 
lowed by an alkaline phosphatase-conjugated 
streptavidin complex for 30 min. The im- 
munoperoxidase andwich was developed with 3- 
amino-9-ethylcarbazole (AEC) and H202 for 8 
rain, yielding a red reaction product, while the 
biotin-streptavidin system was visualized by a 
naphthol AS-MX phosphate/Fast Blue BB salt 
solution for 20 min, yielding a blue reaction prod- 
uct. 
Preparation of the CD6 cRNA for Northern blot 
analysis 
The CD6-cDNA clone 13.3 was a kind gift of 
Dr. B. Seed, General Hospital of Massachusetts, 
Boston, MA, U.S.A. The identity of the insert 
coding for the CD6 antigen was tested by tran- 
sient transfection of the cDNA in cos7 cells and 
precipitation with appropriate mabs (kindly car- 
ried out by Dr. J. Johnson, Institute of Immunol- 
ogy, University of Munich, Munich, F.R.G., 1988, 
unpublished data). The restriction map of the 
clone was established according to standard proto- 
cols (Maniatis et al., 1982) by cleaving the plasmid 
DNA with appropriate restriction endonucleases 
under conditions recommended by the manufac- 
turer (Boehringer, Mannheim, F.R.G.). Digestion 
patterns were analyzed on a 1% agarose gel. The 
CD6 cRNA probe was prepared by in vitro tran- 
scription. Briefly, the 1.5 kb EcoRI fragment of 
the CD6 cDNA was subcloned into the EcoRI-re- 
stricted transcription vector pT3T7 lac (Boeh- 
ringer). The DNA construct was linearized with 
the enzymes BgllI (T3 RNA polymerase reaction) 
and BamHI (T7 RNA polymerase reaction), re- 
spectively, and the in vitro transcription assay was 
performed as described by Melton and Krieg 
(1984), After purification and size determination 
on a 5% acrylamide-8.3 M urea gel the transcrip- 
tion reactions were tested for sense and antisense 
strand by Northern blot analysis. The antisense 
CD6 cRNA (T3 RNA polymerase reaction) was 
used for hybridization of the blot with the brain 
RNA samples. 
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was prehybridized at 58°C in 50% deionized for- 
mamide, 1 M NaC1, 50 mM Tris HC1 pH 7.5, 1% 
sodium dodecyl sulfate (SDS), 10% Denhardt's, 
250/~g/ml Escherichia coli RNA and 100/~g/ml 
denatured salmon sperm DNA for at least 7 h. 
Subsequently the blot was incubated overnight in 
the same mixture additionally containing 10 ng/ml 
32p-labeled antisense CD6 cRNA. Control hy- 
bridizations consecutively were performed on a 
duplicate filter with a TCRy, a TCR/3 and a 
/3-actin cDNA probe using the same hybridization 
protocol. Previous hybridization signals were re- 
moved by washing the filters in 0.1 x SSC, 1% 
SDS at 68 °C for 30 min. 
RNA isolation and Northern blot hybridization 
Total RNA was extracted from snap-frozen 
samples using the guanidinium isothiocyanate 
method (Chirgwin et al., 1979). 20-25/zg of total 
RNA was electrophoresed through a 1.2% 
agarose-formaldehyde gel (Maniatis et al., 1982) 
and transferred to Hybond-N membrane (Amers- 
ham, Buchler, Braunschweig, F.R.G.). The filter 
Results 
Detection of the CD6 antigen by immunohistochem- 
istry 
Using all available anti-CD6 mabs, with the 
combined APAAP-Nissl staining, we observed a 
consistent staining pattern on the four tested brain 
specimens and the various glioma cell lines. 
TABLE 1 
MONOCLONAL ANTIBODIES USED FOR IMMUNOHISTOCHEMICAL STUDIES IN NORMAL HUMAN BRAIN 
Monoclonal lsotype Specificity Source 
antibody 
M-T 211 IgG1 CD6 
M-T 411 IgG1 CD6 
M-T 421 IgG1 CD6 
T 146 IgG1 CD6 
T 147 IgG1 CD6 
T 148 IgG1 CD6 
T 149 IgG1 CD6 
T 150 IgG1 CD6 
T 151 IgG1 CD6 
T 152 IgG1 CD6 
M-T 811 IgG1 CD8 
M-M 42 IgM CD14 
Anti-LC IgG1 CD45 
W6/32 IgG2a MHC class I
BMA 031 IgG2b TCRa,fl 
Identity-T CR delta 1 IgG1 TCR8 
Anti-GFAP IgG1 GFAP 
EBM 11 IgG1 Microglia 
Anti-GC IgG2a Galacto cerebroside 
Rieber 
Rieber 
Rieber 
Rieber 
Rieber 
Rieber 
Rieber 
Rieber 
Rieber 
Rieber, 
Rieber, 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
E.P., Munich, F.R.G. 
Rieber, E.P., Munich, F.R.G. 
Dako, Hamburg, F.R.G. 
ATCC, Rockville, MD, U.S.A. 
Behring, Marburg, F.R.G. 
Biermann, Bad Nauheim, F.R.G. 
Dako, Hamburg, F.R.G. 
Dako, Hamburg, F.R.G. 
Sigma, Deisenhofen, F.R.G. 
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Fig. 4. Restriction map of the CD6 cDNA clone 13.3. B: 
BstXI, Bg: Bg/II, E:EcoRI, H: HindlI, P: Pstl, S: Sau3A, 
Sa: SacI, vector CDM8. 
Anti-CD6 immunoreactive cells were found in 
the grey matter of all examined brain areas (cere- 
bellum, pons, basal ganglia, thalamus, corpus 
amygdaloideum, lobi cerebri), of which basal 
ganglia and cortex cerebelli showed a distinct in- 
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Fig. 5. Expression of CD6 mRNA in brain and various control 
tissues. 20-25 /sg of total RNA was separated on a 1.2% 
agarose-formaldehyde g l and transferred to Hybond-N mem- 
brane. (a) Hybridization with a 32p-labeled CD6-specific 
cRNA (1.5 kb) reveals a 3.1 kb CD6 mRNA in positive control 
tissues (tonsil, thymus) and various brain regions. (b) Hybridi- 
zation with a 32p-labeled B-actin cDNA probe (1.7 kb) was 
used as control for the amount of total RNA applied in each 
lane. Arrows mark the 18 S and 28 S rRNA. 
crease of stained cells. CD6-positive cells were not 
only located in some small vessels and capillaries, 
but could also be detected randomly scattered in 
brain parenchyma (up to 20 CD6-reactive cells per 
section). As depicted in Fig. 1 these CD6-positive 
cells, morphologically characterized by a small cell 
body (about 10 ~tm), showed a staining pattern 
consistent with a cytoplasmic and/or  cell surface 
antigen localization. 
Neither pyramidal neurons nor Purkinje cells 
showed any CD6-positive reaction (Fig. 2). In 
view of the apparent CD6-negative staining of 
glial cells in brain, we examined six different 
.Q 
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,, ~ ~ ~- ,~ . -  
3.1 kb 
t 
0.9  kb  
,I 
1.4kb  
o .g  
Fig. 6. (a)  See legend to Fig. 5a. (b) Hybridization with a 
32p-labeled TCR/3 probe (1.0 kb) performed as described 
above demonstrates only a truncated 0.9 kb transcript in cortex 
parietalis and cortex occipitalis. (c) Hybridization with a 32p_ 
labeled TCR~, probe (0.7 kb) reveals a 1.4 kb full-length 
transcript in tonsil, thymus, pons, thalamus, corpus 
amygdaloideum and cortex frontalis while kidney and basal 
ganglia contain a shortened 0.9 kb transcript. Arrows mark the 
18 S and 28 S rRNA. 
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Fig. 7. Cortex cerebellum stained with anti-human macrophage mab EMB 11 using the APAAP technique. Several EBM ll-positive 
cells are detected inthe stratum granulosum with the typical morphology ofmicroglia. Magnification X 25. 
glioma cell fines and none of them showed any 
CD6 expression (Fig. 3). Tonsil, thymus and PBLs, 
however, revealed a strong reaction pattern corre- 
sponding with the known distribution of T cells 
while on kidney and liver sections only a few 
hematopoietic ells were CD6-immunoreactive. 
Fig. 8. Double immunoenzymatic labeling with anti-LC stained by peroxidase (red) and a biotin-conjugated T152, stained by alkaline 
phosphatase (blue) as described in Materials and Methods. In the area of the basal ganglia a CD6-positive cell 
(arrow) is present next to a CD45-positive capillary. Magnification X 40. 
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The Raji B lymphoma cell line used as negative 
control was CD6-negative. 
On serial brain sections anti-GFAP, anti-GC 
and the anti-microglia marker EBM 11 resulted in 
a staining pattern quite different from patterns 
obtained with anti-CD6 (Fig. 7). In addition the 
failure of the small CD6-positive cells to stain 
with anti-CD45 in the double staining experiments 
exclude them to be lymphocytes (Fig. 8). 
Furthermore, in various brain areas, especially 
in pons and cortex frontalis, staining with an mab 
directed against the delta chain of the T cell 
receptor (TCR) indicated more positive cells than 
with an anti-afl-TCR mab. Incubation with the 
isotype-matched control mab M-T 811 yielded a 
complete lack of staining on the examined brain 
sections. Thus, the T lymphocytes in normal hu- 
man brain detected with anti-TCR reagents ap- 
parently do not express the CD8 T cell differentia- 
tion molecule and are characterized in their major- 
ity by the 73-TCR complex. 
Detection of the CD6 expression by Northern blot 
analysis 
To confirm the immunohistochemical staining 
results, total RNA was extracted from the same 
human brain areas and the various tested control 
tissues. Because of the few CD6-positive cells 
scattered in brain parenchyma only a weak hy- 
bridization signal could be expected. Therefore 
Northern blot analysis was performed using a 
CD6-specific antisense cRNA probe in order to 
increase hybridization efficiency (Cox et al., 1984). 
For preparation of the cRNA a restriction map 
of the CD6 cDNA clone 13.3 was constructed 
(Fig. 4). Subsequently the EcoRI fragment was 
subcloned in the vector pT3T7 lac. Employing 
antisense strand of the transcription reaction as 
probe for Northern blot analysis we detected a 3.1 
kb CD6 mRNA in cerebellum, basal ganglia, 
cortex parietalis and cortex occipitalis. Thus, the 
CD6-specific message in brain is of the same size 
as the CD6 mRNA in the tested lymphoid tissues 
(Fig. 5a). In a comparative analysis using a hu- 
man fl-actin cDNA probe as standard we found 
basal ganglia to exhibit the strongest CD6 mRNA 
hybridization signal followed by cerebellum and 
cortex cerebri areas (Fig. 5b). 
Control hybridizations with probes specific for 
the different TCR heterodimers do not correlate 
with the CD6 mRNA signal and thus make it 
unlikely that the detected CD6 mRNA found in 
brain is expressed by T lymphocytes (Fig. 6). In 
accordance with staining results Northern blot 
analysis with the TCRy cDNA probe showed a 1.4 
kb functional transcript in pons, thalamus, corpus 
amygdaloideum and cortex frontalis (Fig. 6c), 
while hybridization with the TCRfl cDNA only 
revealed a shortened (0.9 kb), non-functional mes- 
sage in cortex parietalis and cortex occipitalis (Fig. 
6b). 
Discussion 
The present study provides direct evidence that 
CD6 expression is not exclusively restricted to 
cells of hematopoietic origin but is also found in 
normal human brain parenchyma. 
Staining with several mabs directed against dif- 
ferent hematopoietic cell types on serial sections 
excluded the infiltration of CD6-positive blood 
cells in brain tissue and a distribution pattern 
distinct from that obtained with anti-CD6 mabs 
was observed. Various reagents directed against 
lymphocyte antigens were used but failed to stain 
the small CD6-positive cells. In double staining 
experiments with the anti-lymphocyte marker 
anti-LC, the CD6-posit ive cells in brain 
parenchyma showed no CD45 reactivity and were 
also negative for staining with additional anti-CD 
reagents (CDla, b, c, CD8 and CD14). Rare T 
lymphocytes were detected using anti-TCR re- 
agents which were distinct from the CD6-positive 
cells. These findings were confirmed by Northern 
blot analysis employing a TCRfi and a TCR7 
probe, respectively. 
For further characterization of the CD6-posi- 
tive cells in brain parenchyma nti-CD6 labeling 
was compared with anti-GFAP staining showing 
no coincidence. Microglia as source for the CD6- 
reactive cells was excluded by staining with EBM 
11. Neither the morphology nor the frequency of 
EBM ll-positive cells agree with the CD6-staining 
pattern (see Fig. 7). Similar results were obtained 
with the anti-oligodendrocyte marker anti-GC. In 
addition none of the tested glial cell lines provided 
any CD6-positive reaction. These results agree 
with previous immunoperoxidase studies reporting 
a lack of anti-T12 staining in the white matter of 
human brain (Hauser et al., 1983), Furthermore 
the prominent motor neurons (Purkinje cells, 
pyramidal neurons) failed any CD6 immunoreac- 
tivity ascertained with the combined APAAP-Nissl 
staining. 
Because of their anatomical localization and 
their morphology the CD6-positive cells in brain 
parenchyma can be discussed as a small neuronal 
cell type. Additional neuroanatomical studies such 
as electron microscopy analyses are required to 
establish definitively the nature of the CD6-reac- 
tive cells in brain. 
In contrast o the APAAP-Nissl staining, CD6 
mRNA could not be demonstrated in all ex- 
amined brain areas. The paucity of CD6-reactive 
cells present in CNS (7 in 100 cells) may explain 
the difference between immunohistochemical and 
Northern blot results. 
Besides the fact that RNA might be lost during 
preparation, hybridization even using a cRNA 
probe is not sensitive enough to detect the smal- 
lest amounts of the CD6 message. The stronger 
hybridization signals in the mRNA of some brain 
areas might indicate that these regions contain 
more CD6-positive cells. Indeed in basal ganglia 
and cerebellum more CD6-stained cells were de- 
tected correlating with a relative strong CD6 
mRNA signal. 
The functional role of lymphocyte differentia- 
tion antigens expressed by neural cells is still 
unknown. As the function of the CD6 molecule on 
B and T lymphocytes i  not known so far, the role 
of CD6 on brain cells is even more puzzling. 
Perhaps the few CD6-positive cells scattered in 
normal CNS tissue may represent cells in a 'be 
prepared' condition confirming the increasing evi- 
dence for the immunocompetence of the CNS. 
Possibly brain cells can be induced to express 
CD6 antigen in response to an immunological 
stimulus as shown for MHC class II and intercel- 
lular adhesion molecule 1 (ICAM-1) (Massa and 
ter Meulen, 1987; Frohmann et al., 1989). Up to 
now only the stimulating effect of different anti- 
CD6 mabs on mature T cells has been shown 
(Rieber et al., 1986; Swack et al., 1988). 
Furthermore antigenic sharing may provide a 
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molecular explication for abnormalities in im- 
mune and central nervous systems based on an 
immunological attack against a common antigen 
or conversely a more positive aspect: coexpressed 
antigens may be involved in the cellular interac- 
tions and the reciprocal functional modulation 
between the two systems to accomplish the abun- 
dance of information derived from the internal 
" and external environment and to maintain a stable 
state of the organism. 
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